Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients
Authors
Keywords
Breast cancer, Disseminated tumor cells, Circulating tumor cells, CTC, Blood, Bone marrow, Comparison
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 139, Issue 6, Pages 1055-1062
Publisher
Springer Nature
Online
2013-03-22
DOI
10.1007/s00432-013-1418-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
- (2012) Kjersti Tjensvoll et al. BMC CANCER
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
- (2011) Brigitte Rack et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device
- (2011) Mary Nora Dickson et al. Biomicrofluidics
- Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer
- (2011) D J E Peeters et al. BRITISH JOURNAL OF CANCER
- Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437
- (2011) M. M. Reinholz et al. CLINICAL CANCER RESEARCH
- Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse--A European Pooled Analysis
- (2011) W. Janni et al. CLINICAL CANCER RESEARCH
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort
- (2010) Foluso O. Ademuyiwa et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of minimal residual disease in blood and bone marrow in early stage breast cancer
- (2010) Savitri Krishnamurthy et al. CANCER
- Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
- (2009) A Daskalaki et al. BRITISH JOURNAL OF CANCER
- Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
- (2009) Nikolaos Xenidis et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
- (2009) Minetta C. Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
- (2008) M J Slade et al. BRITISH JOURNAL OF CANCER
- Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen
- (2008) Christian Schindlbeck et al. CLINICAL & EXPERIMENTAL METASTASIS
- Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
- (2008) M. Ignatiadis et al. CLINICAL CANCER RESEARCH
- Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse
- (2008) Katharina Pachmann et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now